Literature DB >> 34403464

Mass Spectrometry-Based Detection of Beta Lactam Hydrolysis Enables Rapid Detection of Beta Lactamase Mediated Antibiotic Resistance.

Raymond T Suhandynata1, Kyle Lund1, Andrés M Caraballo-Rodríguez2, Sharon L Reed1, Pieter C Dorrestein2, Robert L Fitzgerald1, Nicholas J Bevins1.   

Abstract

OBJECTIVE: Antibiotic resistance by beta lactamase expression is a serious and growing threat. We aimed to determine whether beta-lactamase activity is detectable in urine specimens to enable faster identification of resistance.
METHODS: Urine specimens from patients with extended spectrum beta lactamase (ESBL)-expressing urinary infections were incubated with beta lactam antibiotics. Beta lactam hydrolysis was determined by mass spectrometry methods.
RESULTS: Ceftriaxone hydrolysis was observed in 45 of 45 ESBL-containing specimens from patients not treated with a beta lactamase inhibitor before specimen collection. Ceftriaxone hydrolysis was not observed in 108 of 108 non-ESBL-containing specimens. Spiking studies show that beta lactam hydrolysis can be observed within 30 minutes. Beta lactam hydrolysis is evidenced by mass spectrometry preceded by either liquid chromatography or matrix-assisted laser desorption ionization specimen processing methods.
CONCLUSION: Clinically significant beta lactamase activity is detectable directly from urine specimens. The described methods would enable the detection of beta lactam resistance 24 to 48 hours sooner than culture based methods. © American Society for Clinical Pathology, 2021. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  ESBL; antibiotic resistance; antibiotic resistance testing; beta lactam hydrolysis; beta lactamase; mass-spectrometry; urinary tract infection

Mesh:

Substances:

Year:  2022        PMID: 34403464      PMCID: PMC8900932          DOI: 10.1093/labmed/lmab068

Source DB:  PubMed          Journal:  Lab Med        ISSN: 0007-5027


  34 in total

1.  General principles of antimicrobial therapy.

Authors:  Surbhi Leekha; Christine L Terrell; Randall S Edson
Journal:  Mayo Clin Proc       Date:  2011-02       Impact factor: 7.616

2.  Towards the early detection of β-lactamase-producing Enterobacteriaceae by MALDI-TOF MS analysis.

Authors:  Marina Oviaño; Marta Gómara; Maria José Barba; María José Revillo; Luis Pedro Barbeyto; Germán Bou
Journal:  J Antimicrob Chemother       Date:  2017-08-01       Impact factor: 5.790

Review 3.  Industrial production of beta-lactam antibiotics.

Authors:  R P Elander
Journal:  Appl Microbiol Biotechnol       Date:  2003-04-03       Impact factor: 4.813

4.  Prevalence and risk factors for extended spectrum Beta-lactamase-producing uropathogens in patients with urinary tract infection.

Authors:  Dong Sup Lee; Chung Bum Lee; Seung-Ju Lee
Journal:  Korean J Urol       Date:  2010-07-20

Review 5.  Extended-spectrum beta-lactamases: implications for the clinical laboratory and therapy.

Authors:  Sohei Harada; Yoshikazu Ishii; Keizo Yamaguchi
Journal:  Korean J Lab Med       Date:  2008-12

6.  Impact of Delayed Appropriate Antibiotic Therapy on Patient Outcomes by Antibiotic Resistance Status From Serious Gram-negative Bacterial Infections.

Authors:  Nicole Gidaya Bonine; Ariel Berger; Arman Altincatal; Rosa Wang; Tarun Bhagnani; Patrick Gillard; Thomas Lodise
Journal:  Am J Med Sci       Date:  2018-11-22       Impact factor: 2.378

Review 7.  Essential medicines for universal health coverage.

Authors:  Veronika J Wirtz; Hans V Hogerzeil; Andrew L Gray; Maryam Bigdeli; Cornelis P de Joncheere; Margaret A Ewen; Martha Gyansa-Lutterodt; Sun Jing; Vera L Luiza; Regina M Mbindyo; Helene Möller; Corrina Moucheraud; Bernard Pécoul; Lembit Rägo; Arash Rashidian; Dennis Ross-Degnan; Peter N Stephens; Yot Teerawattananon; Ellen F M 't Hoen; Anita K Wagner; Prashant Yadav; Michael R Reich
Journal:  Lancet       Date:  2016-11-08       Impact factor: 79.321

Review 8.  Environmental factors influencing the development and spread of antibiotic resistance.

Authors:  Johan Bengtsson-Palme; Erik Kristiansson; D G Joakim Larsson
Journal:  FEMS Microbiol Rev       Date:  2018-01-01       Impact factor: 16.408

Review 9.  Molecular Mechanisms, Epidemiology, and Clinical Importance of β-Lactam Resistance in Enterobacteriaceae.

Authors:  Giulia De Angelis; Paola Del Giacomo; Brunella Posteraro; Maurizio Sanguinetti; Mario Tumbarello
Journal:  Int J Mol Sci       Date:  2020-07-18       Impact factor: 5.923

10.  Prevalence and Molecular Epidemiology of Extended-Spectrum-β-Lactamase (ESBL)-Producing Escherichia coli From Multiple Sectors of the Swine Industry in Korea: A Korean Nationwide Monitoring Program for a One Health Approach to Combat Antimicrobial Resistance.

Authors:  Young Ah Kim; Hyunsoo Kim; Young Hee Seo; Go Eun Park; Hyukmin Lee; Kyungwon Lee
Journal:  Ann Lab Med       Date:  2021-05-01       Impact factor: 3.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.